AAAAAA

   
Results: 1-9 |
Results: 9
MEASUREMENT CHARACTERISTICS OF 2 ASTHMA SYMPTOM DIARY SCALES FOR USE IN CLINICAL-TRIALS
Authors: SANTANELLO NC BARBER BL REISS TF FRIEDMAN BS JUNIPER EF ZHANG J
Citation: Nc. Santanello et al., MEASUREMENT CHARACTERISTICS OF 2 ASTHMA SYMPTOM DIARY SCALES FOR USE IN CLINICAL-TRIALS, The European respiratory journal, 10(3), 1997, pp. 646-651
MONTELUKAST, A LEUKOTRIENE RECEPTOR ANTAGONIST, INHIBITS EXERCISE-INDUCED BRONCHOCONSTRICTION IN 6 TO 14-YEAR-OLD CHILDREN
Authors: KEMP JP DOCKHORN RJ SHAPIRO GG NGUYEN HH GUERREIRO DA REISS TF FRIEDMAN BS KNORR BA
Citation: Jp. Kemp et al., MONTELUKAST, A LEUKOTRIENE RECEPTOR ANTAGONIST, INHIBITS EXERCISE-INDUCED BRONCHOCONSTRICTION IN 6 TO 14-YEAR-OLD CHILDREN, Journal of allergy and clinical immunology, 99(1), 1997, pp. 1314-1314
PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF A NOVEL LEUKOTRIENE BIOSYNTHESIS INHIBITOR, MK-0591, IN HEALTHY-VOLUNTEERS
Authors: UEMATSU T KANAMARU M KOSUGE K HARA K UCHIYAMA U TAKENAGA N TANAKA W FRIEDMAN BS NAKASHIMA M
Citation: T. Uematsu et al., PHARMACOKINETIC AND PHARMACODYNAMIC ANALYSIS OF A NOVEL LEUKOTRIENE BIOSYNTHESIS INHIBITOR, MK-0591, IN HEALTHY-VOLUNTEERS, British journal of clinical pharmacology, 40(1), 1995, pp. 59-66
THE EFFECT OF MK-0591, A NOVEL 5-LIPOXYGENASE ACTIVATING PROTEIN INHIBITOR, ON LEUKOTRIENE BIOSYNTHESIS AND ALLERGEN-INDUCED AIRWAY RESPONSES IN ASTHMATIC SUBJECTS IN-VIVO
Authors: DIAMANT Z TIMMERS MC VANDERVEEN H FRIEDMAN BS DESMET M DEPRE M HILLIARD D BEL EH STERK PJ
Citation: Z. Diamant et al., THE EFFECT OF MK-0591, A NOVEL 5-LIPOXYGENASE ACTIVATING PROTEIN INHIBITOR, ON LEUKOTRIENE BIOSYNTHESIS AND ALLERGEN-INDUCED AIRWAY RESPONSES IN ASTHMATIC SUBJECTS IN-VIVO, Journal of allergy and clinical immunology, 95(1), 1995, pp. 42-51
BLOCKADE OF LEUKOTRIENE PRODUCTION BY A SINGLE ORAL DOSE OF MK-0591 IN ACTIVE ULCERATIVE-COLITIS
Authors: HILLINGSO J KJELDSEN J LAURITSEN K VONSPRECKELSEN S DEPRE M FRIEDMAN BS MALMSTROM K SHINGO S BUKHAVE K RASKMADSEN J
Citation: J. Hillingso et al., BLOCKADE OF LEUKOTRIENE PRODUCTION BY A SINGLE ORAL DOSE OF MK-0591 IN ACTIVE ULCERATIVE-COLITIS, Clinical pharmacology and therapeutics, 57(3), 1995, pp. 335-341
A CLINICOPATHOLOGICAL STUDY OF 10 PATIENTS WITH RECURRENT UNEXPLAINEDFLUSHING
Authors: FRIEDMAN BS GERMANO P MILETTI J METCALFE DD
Citation: Bs. Friedman et al., A CLINICOPATHOLOGICAL STUDY OF 10 PATIENTS WITH RECURRENT UNEXPLAINEDFLUSHING, Journal of allergy and clinical immunology, 93(1), 1994, pp. 53-60
SELECTIVE BLOCKADE OF RECTAL LEUKOTRIENE-B4 (LTB4) AND SYSTEMIC LEUKOTRIENE PRODUCTION BY A SINGLE, ORAL DOSE OF MK-591 IN PATIENTS WITH ACTIVE ULCERATIVE-COLITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Authors: HILLINGSO J KJELDSEN J LAURSEN LS LAURITSEN K VONSPRECKELSEN S DEPRE M FRIEDMAN BS MALMSTROM K SHINGO S BUKHAVE K RASKMADSEN J
Citation: J. Hillingso et al., SELECTIVE BLOCKADE OF RECTAL LEUKOTRIENE-B4 (LTB4) AND SYSTEMIC LEUKOTRIENE PRODUCTION BY A SINGLE, ORAL DOSE OF MK-591 IN PATIENTS WITH ACTIVE ULCERATIVE-COLITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Gastroenterology, 106(4), 1994, pp. 10000698-10000698
COMPARISON OF AZELASTINE AND CHLORPHENIRAMINE IN THE TREATMENT OF MASTOCYTOSIS
Authors: FRIEDMAN BS SANTIAGO ML BERKEBILE C METCALFE DD
Citation: Bs. Friedman et al., COMPARISON OF AZELASTINE AND CHLORPHENIRAMINE IN THE TREATMENT OF MASTOCYTOSIS, Journal of allergy and clinical immunology, 92(4), 1993, pp. 520-526
THE EFFECT OF MK-591, A POTENT ORAL LEUKOTRIENE BIOSYNTHESIS INHIBITOR, ON ALLERGEN-INDUCED AIRWAY RESPONSES IN ASTHMATIC SUBJECTS
Authors: DIAMANT Z TIMMERS MC VANDERVEEN H FRIEDMAN BS DESMET M TANAKA W DEPRE M BEL EH DIJKMAN JH STERK PJ
Citation: Z. Diamant et al., THE EFFECT OF MK-591, A POTENT ORAL LEUKOTRIENE BIOSYNTHESIS INHIBITOR, ON ALLERGEN-INDUCED AIRWAY RESPONSES IN ASTHMATIC SUBJECTS, The American review of respiratory disease, 147(4), 1993, pp. 446-446
Risultati: 1-9 |